Nerve growth factor (NGF) has been shown to be upregulated in joints affected by osteoarthritis, many cell types in the joint express NGF receptors, and an important NGF effect is to increase pain ...

Before chronic pain research had a name for its nemesis, Dr. Levi-Montalcini discovered the molecule that would revolutionize its treatment: Nerve Growth Factor. Exiled, underestimated, and elegant to ...

Once pharma’s great hope to replace opioid painkillers, it looks like the end for nerve growth factor (NGF) inhibitors after Regeneron Pharmaceuticals Inc. quietly axed fasinumab, the late-stage ...

Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with nonsteroidal anti-inflammatory compounds and opioids that lack efficacy and that are associated with ...